BACKGROUND: Numerous techniques have been developed for localizing lymph nodes before surgical resection and for their histological assessment. Nondestructive high-resolution transcapsule optical imaging of lymph nodes offers the potential for in situ assessment of metastatic involvement, potentially during surgical procedures. METHODS: Three-dimensional optical coherence tomography (3-D OCT) was used for imaging and assessing resected popliteal lymph nodes from a preclinical rat metastatic tumor model over a 9-day time-course study after tumor induction. The spectral-domain OCT system utilized a center wavelength of 800 nm, provided axial and transverse resolutions of 3 and 12 μm, respectively, and performed imaging at 10,000 axial scans per second. RESULTS: OCT is capable of providing high-resolution label-free images of intact lymph node microstructure based on intrinsic optical scattering properties with penetration depths of ~1-2 mm. The results demonstrate that OCT is capable of differentiating normal, reactive, and metastatic lymph nodes based on microstructural changes. The optical scattering and structural changes revealed by OCT from day 3 to day 9 after the injection of tumor cells into the lymphatic system correlate with inflammatory and immunological changes observed in the capsule, precortical regions, follicles, and germination centers found during histopathology. CONCLUSIONS: We report for the first time a longitudinal study of 3-D transcapsule OCT imaging of intact lymph nodes demonstrating microstructural changes during metastatic infiltration. These results demonstrate the potential of OCT as a technique for intraoperative, real-time in situ 3-D optical biopsy of lymph nodes for the intraoperative staging of cancer.
BACKGROUND: Numerous techniques have been developed for localizing lymph nodes before surgical resection and for their histological assessment. Nondestructive high-resolution transcapsule optical imaging of lymph nodes offers the potential for in situ assessment of metastatic involvement, potentially during surgical procedures. METHODS: Three-dimensional optical coherence tomography (3-D OCT) was used for imaging and assessing resected popliteal lymph nodes from a preclinical rat metastatic tumor model over a 9-day time-course study after tumor induction. The spectral-domain OCT system utilized a center wavelength of 800 nm, provided axial and transverse resolutions of 3 and 12 μm, respectively, and performed imaging at 10,000 axial scans per second. RESULTS:OCT is capable of providing high-resolution label-free images of intact lymph node microstructure based on intrinsic optical scattering properties with penetration depths of ~1-2 mm. The results demonstrate that OCT is capable of differentiating normal, reactive, and metastatic lymph nodes based on microstructural changes. The optical scattering and structural changes revealed by OCT from day 3 to day 9 after the injection of tumor cells into the lymphatic system correlate with inflammatory and immunological changes observed in the capsule, precortical regions, follicles, and germination centers found during histopathology. CONCLUSIONS: We report for the first time a longitudinal study of 3-D transcapsule OCT imaging of intact lymph nodes demonstrating microstructural changes during metastatic infiltration. These results demonstrate the potential of OCT as a technique for intraoperative, real-time in situ 3-D optical biopsy of lymph nodes for the intraoperative staging of cancer.
Authors: Thomas Klein; Wolfgang Wieser; Christoph M Eigenwillig; Benjamin R Biedermann; Robert Huber Journal: Opt Express Date: 2011-02-14 Impact factor: 3.894
Authors: Maaike de Boer; Carolien H M van Deurzen; Jos A A M van Dijck; George F Borm; Paul J van Diest; Eddy M M Adang; Johan W R Nortier; Emiel J T Rutgers; Caroline Seynaeve; Marian B E Menke-Pluymers; Peter Bult; Vivianne C G Tjan-Heijnen Journal: N Engl J Med Date: 2009-08-13 Impact factor: 91.245
Authors: Nancy J Fischbein; Susan M Noworolski; Roland G Henry; Michael J Kaplan; William P Dillon; Sarah J Nelson Journal: AJNR Am J Neuroradiol Date: 2003-03 Impact factor: 3.825
Authors: Yijing Xie; Laura-Adela Harsan; Thomas Bienert; Robert D Kirch; Dominik von Elverfeldt; Ulrich G Hofmann Journal: Biomed Opt Express Date: 2017-01-05 Impact factor: 3.732
Authors: Lian Duan; Michael D McRaven; Wenzhong Liu; Xiao Shu; Jianmin Hu; Cheng Sun; Ronald S Veazey; Thomas J Hope; Hao F Zhang Journal: J Biomed Opt Date: 2017-05-01 Impact factor: 3.170
Authors: Manmohan Singh; Raksha Raghunathan; Victor Piazza; Anjul M Davis-Loiacono; Alex Cable; Tegy J Vedakkan; Trevor Janecek; Michael V Frazier; Achuth Nair; Chen Wu; Irina V Larina; Mary E Dickinson; Kirill V Larin Journal: Biomed Opt Express Date: 2016-05-19 Impact factor: 3.732
Authors: Sarah J Erickson-Bhatt; Ryan M Nolan; Nathan D Shemonski; Steven G Adie; Jeffrey Putney; Donald Darga; Daniel T McCormick; Andrew J Cittadine; Adam M Zysk; Marina Marjanovic; Eric J Chaney; Guillermo L Monroy; Fredrick A South; Kimberly A Cradock; Z George Liu; Magesh Sundaram; Partha S Ray; Stephen A Boppart Journal: Cancer Res Date: 2015-09-15 Impact factor: 12.701
Authors: Ryan M Nolan; Steven G Adie; Marina Marjanovic; Eric J Chaney; Fredrick A South; Guillermo L Monroy; Nathan D Shemonski; Sarah J Erickson-Bhatt; Ryan L Shelton; Andrew J Bower; Douglas G Simpson; Kimberly A Cradock; Z George Liu; Partha S Ray; Stephen A Boppart Journal: BMC Cancer Date: 2016-02-23 Impact factor: 4.430